Program Manager
CurrentOncoC4 is a privately-held, late-stage biopharmaceutical company that is actively engaged in the discovery and development of novel biologicals for cancer treatment.
Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
David Cerna is listed as Program Manager at OncoC4, Inc., based in Rockville, Maryland, United States. AeroLeads shows a matched LinkedIn profile for David Cerna.
David Cerna previously worked as Associate Director, Pipeline Project Manager at GSK Vaccines at Gsk and Senior Project Manager at Gsk. David Cerna holds Doctor Of Philosophy (Ph.D.), Biochemistry And Molecular Biology from University Of California, Davis.
This section adds company-level context without repeating David Cerna's masked contact details.
Review company-level records connected to David Cerna before choosing the right outreach path.
Experienced scientist with a demonstrated history of working in the biotechnology industry. Skilled in Bioinformatics, Oncology, Molecular Biology, Biotechnology, and Drug Discovery.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Rockville, Maryland, US
OncoC4 is a privately-held, late-stage biopharmaceutical company that is actively engaged in the discovery and development of novel biologicals for cancer treatment.
Brentford, Middlesex, GB
GSK’s vaccines business is one of the largest in the world. It has the broadest portfolio of the industry, making available 39 pediatric, adolescent, adult and traveler vaccines that protect against 21 different diseases including hepatitis, meningitis, influenza, pneumococcal disease and rotavirus. GSK has 15 candidate vaccines in development against.
We develop your assays and manage global logistics, speeding to actionable answers. We use biomarkers to stratify patients, incomparably improving your R&D efficiency and success. We manage every aspect of your clinical trials from sites to biomarkers to diagnostics, all under a single roof. In short: we dramatically accelerate your pathway from proof of.
Hackensack, New Jersey, US
Champions Oncology’s TumorGraft platform and Translational Oncology Solutions is an innovative platform technology able to accelerate the development of oncology drugs by predicting their clinical effectiveness.This platform is based on primary tumor models of cancer that preserve the original characteristics of the human tumor. As a result, Champions.
Reston, VA, US
The Molecular Radiation Therapeutics Branch (MRTB) was initiated in June of 2001 with the goal of developing target based strategies for enhancing tumor sensitivity and protecting normal tissue during radiotherapy.
Quick answers generated from the profile data available on this page.
David Cerna works for OncoC4, Inc..
David Cerna is listed as Program Manager at OncoC4, Inc..
David Cerna is based in Rockville, Maryland, United States while working with OncoC4, Inc..
David Cerna has worked for Oncoc4, Inc., Gsk, Precision For Medicine, Champions Oncology, Inc., and Saic.
You can use AeroLeads to view verified contact signals for David Cerna at OncoC4, Inc., including work email, phone, and LinkedIn data when available.
David Cerna holds Doctor Of Philosophy (Ph.D.), Biochemistry And Molecular Biology from University Of California, Davis.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts